Tower Research Capital (TRC)’s Quipt Home Medical QIPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-26
Closed -$92 5478
2025
Q4
$92 Buy
+26
New +$69 ﹤0.01% 5048
2025
Q3
Sell
-14,125
Closed -$25.3K 5546
2025
Q2
$25.3K Buy
14,125
+9,819
+228% +$19.4K ﹤0.01% 3534
2025
Q1
$10K Sell
4,306
-3,297
-43% -$9.04K ﹤0.01% 3685
2024
Q4
$23.2K Buy
7,603
+3,443
+83% +$9.27K ﹤0.01% 3078
2024
Q3
$12.1K Sell
4,160
-2,578
-38% -$7.96K ﹤0.01% 3614
2024
Q2
$21.7K Buy
6,738
+6,172
+1,090% +$22.1K ﹤0.01% 3713
2024
Q1
$2.47K Sell
566
-6,189
-92% -$28K ﹤0.01% 5032
2023
Q4
$34.4K Buy
6,755
+3,956
+141% +$18.9K ﹤0.01% 3348
2023
Q3
$14.2K Buy
2,799
+1,572
+128% +$8.43K ﹤0.01% 3697
2023
Q2
$6.55K Buy
+1,227
New +$7.24K ﹤0.01% 4686

Tower Research Capital (TRC)'s QIPT Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Quipt Home Medical (QIPT) in Q1 2026, closing a stake of 26 shares — an estimated $92 sold.

Tower Research Capital (TRC) first reported a position in QIPT in Q2 2023 and held it in 10 quarters. The position peaked at $34.4K in Q4 2023. 0 funds tracked by Wall St. Rank hold QIPT as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining Quipt Home Medical position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 26 Quipt Home Medical shares in Q1 2026, an estimated $92.
  • Tower Research Capital (TRC) first reported a position in Quipt Home Medical in Q2 2023 and held it in 10 quarters.
  • Tower Research Capital (TRC)'s Quipt Home Medical position peaked at $34.4K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Quipt Home Medical as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.